Chromadex Corp Stock Today
| CDXC Stock | USD 3.40 0.45 15.25% |
Performance17 of 100
| Odds Of DistressLess than 9
|
Chromadex Corp is trading at 3.40 as of the 25th of April 2024, a 15.25 percent increase since the beginning of the trading day. The stock's open price was 2.95. Chromadex Corp has less than a 9 % chance of experiencing financial distress in the next few years and had a solid performance during the last 90 days. Equity ratings for Chromadex Corp are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 26th of March 2024 and ending today, the 25th of April 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 15th of July 2008 | Category Healthcare | Classification Health Care |
ChromaDex Corporation operates as a bioscience company focusing on healthy aging. ChromaDex Corporation is headquartered in Los Angeles, California. Chromadex Corp operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. The company has 75.31 M outstanding shares of which 1.32 M shares are currently shorted by private and institutional investors with about 2.59 trading days to cover. More on Chromadex Corp
Moving together with Chromadex Stock
| 0.89 | YS | YS Biopharma | PairCorr |
| 0.91 | DSGN | Design Therapeutics Financial Report 14th of May 2024 | PairCorr |
Moving against Chromadex Stock
| 0.91 | ETON | Eton Pharmaceuticals Financial Report 9th of May 2024 | PairCorr |
| 0.79 | KA | Kineta Inc Financial Report 9th of May 2024 | PairCorr |
| 0.79 | EYPT | Eyepoint Pharmaceuticals Earnings Call This Week | PairCorr |
| 0.7 | VRAX | Virax Biolabs Group Fiscal Year End 12th of June 2024 | PairCorr |
| 0.67 | DRMA | Dermata Therapeutics Financial Report 9th of May 2024 | PairCorr |
| 0.66 | BNR | Burning Rock BiotechLtd Financial Report 4th of June 2024 | PairCorr |
| 0.52 | EFTR | Effector Therapeutics Financial Report 14th of May 2024 | PairCorr |
Follow Valuation Options Odds of Bankruptcy
Financial Report 8th of May 2024
Chromadex Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Chromadex Corp's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Chromadex Corp or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Frank Jaksch | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Life Sciences Tools & Services, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Life Sciences Tools & Services, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering Chromadex Corp report their recommendations after researching Chromadex Corp's financial statements, talking to executives and customers, or listening in on Chromadex Corp's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Chromadex Corp. The Chromadex consensus assessment is calculated by taking the average forecast from all of the analysts covering Chromadex Corp. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the analysis of Chromadex Corp's profitability, liquidity, and operating efficiency, Chromadex Corp is not in a good financial situation at this time. It has a very high probability of going through financial hardship in May. Financial strength of Chromadex Corp is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Chromadex Corp's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Chromadex Corp's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Chromadex Corp's financial leverage. It provides some insight into what part of Chromadex Corp's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Chromadex Corp (CDXC) is traded on NASDAQ Exchange in USA. It is located in 10900 Wilshire Blvd, Los Angeles, CA, United States, 90024 and employs 106 people. Chromadex Corp is listed under Life Sciences Tools & Services category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 256.05 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Chromadex Corp's market, we take the total number of its shares issued and multiply it by Chromadex Corp's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Chromadex Corp conducts business under Life Sciences Tools & Services sector and is part of Health Care industry. The entity has 75.31 M outstanding shares of which 1.32 M shares are currently shorted by private and institutional investors with about 2.59 trading days to cover.
Chromadex Corp currently holds about 16.87 M in cash with 7.04 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.25.
Check Chromadex Corp Probability Of Bankruptcy
Ownership AllocationChromadex Corp holds a total of 75.31 Million outstanding shares. Chromadex Corp retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Chromadex Ownership Details
Chromadex Stock Price Odds Analysis
What are Chromadex Corp's target price odds to finish over the current price? Based on a normal probability distribution, the odds of Chromadex Corp jumping above the current price in 90 days from now is about 17.78%. The Chromadex Corp probability density function shows the probability of Chromadex Corp stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days Chromadex Corp has a beta of -0.7406 suggesting as returns on the benchmark increase, returns on holding Chromadex Corp are expected to decrease at a much lower rate. During a bear market, however, Chromadex Corp is likely to outperform the market. Moreover, chromadex Corp has an alpha of 1.6191, implying that it can generate a 1.62 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of Chromadex Corp to move above the current price in 90 days from now is about 17.78 (This Chromadex Corp probability density function shows the probability of Chromadex Stock to fall within a particular range of prices over 90 days) .
Chromadex Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Chromadex Corp that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Chromadex Corp's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Chromadex Corp's value.| Instituion | Recorded On | Shares | |
| Qube Research & Technologies | 2023-12-31 | 131.8 K | |
| Millennium Management Llc | 2023-12-31 | 125.1 K | |
| Royal Bank Of Canada | 2023-12-31 | 119 K | |
| Cambridge Invest Research Advisors, Inc. | 2023-12-31 | 117.8 K | |
| Connor Clark & Lunn Inv Mgmt Ltd | 2023-12-31 | 116.5 K | |
| Northern Trust Corp | 2023-12-31 | 94.1 K | |
| Bank Of New York Mellon Corp | 2023-12-31 | 86.1 K | |
| Silverberg Bernstein Capital Management Llc | 2023-12-31 | 82.8 K | |
| Squarepoint Ops Llc | 2023-12-31 | 61.9 K | |
| Vanguard Group Inc | 2023-12-31 | 3 M | |
| Tieton Capital Management, Llc | 2023-12-31 | 2.9 M |
Chromadex Corp Historical Income Statement
Chromadex Corp Income Statement is one of the three primary financial statements used for reporting Chromadex's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Chromadex Corp revenue and expense. Chromadex Corp Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At present, Chromadex Corp's Gross Profit is projected to increase significantly based on the last few years of reporting. The current year's Cost Of Revenue is expected to grow to about 34.4 M, whereas Depreciation And Amortization is forecasted to decline to about 863.7 K. View More FundamentalsChromadex Stock Against Markets
Picking the right benchmark for Chromadex Corp stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Chromadex Corp stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Chromadex Corp is critical whether you are bullish or bearish towards Chromadex Corp at a given time. Please also check how Chromadex Corp's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Chromadex Corp without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Price Ceiling Movement Now
Price Ceiling MovementCalculate and plot Price Ceiling Movement for different equity instruments |
| All Next | Launch Module |
Chromadex Corp Corporate Directors
Chromadex Corp corporate directors refer to members of a Chromadex Corp board of directors. The board of directors generally takes responsibility for the Chromadex Corp's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Chromadex Corp's board members must vote for the resolution. The Chromadex Corp board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Brianna Gerber | Senior Director of FP&A, IR Contact Officer | Profile | |
| William Smithburg | Independent Director | Profile | |
| Jeffrey Baxter | Independent Director | Profile | |
| Reid Dabney | Independent Director | Profile |
How to buy Chromadex Stock?
Before investing in Chromadex Corp, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Chromadex Corp. To buy Chromadex Corp stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Chromadex Corp. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Chromadex Corp stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Chromadex Corp stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Chromadex Corp stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Chromadex Corp, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Chromadex Stock please use our How to Invest in Chromadex Corp guide.
Already Invested in Chromadex Corp?
The danger of trading Chromadex Corp is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Chromadex Corp is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Chromadex Corp. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Chromadex Corp is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Chromadex Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Chromadex Corp's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Chromadex Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Chromadex Corp Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chromadex Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest. For information on how to trade Chromadex Stock refer to our How to Trade Chromadex Stock guide.You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Complementary Tools for Chromadex Stock analysis
When running Chromadex Corp's price analysis, check to measure Chromadex Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chromadex Corp is operating at the current time. Most of Chromadex Corp's value examination focuses on studying past and present price action to predict the probability of Chromadex Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chromadex Corp's price. Additionally, you may evaluate how the addition of Chromadex Corp to your portfolios can decrease your overall portfolio volatility.
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Stocks Directory Find actively traded stocks across global markets | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |
Is Chromadex Corp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chromadex Corp. If investors know Chromadex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chromadex Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.07) | Revenue Per Share 1.114 | Quarterly Revenue Growth 0.01 | Return On Assets (0.06) | Return On Equity (0.17) |
The market value of Chromadex Corp is measured differently than its book value, which is the value of Chromadex that is recorded on the company's balance sheet. Investors also form their own opinion of Chromadex Corp's value that differs from its market value or its book value, called intrinsic value, which is Chromadex Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chromadex Corp's market value can be influenced by many factors that don't directly affect Chromadex Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chromadex Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Chromadex Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chromadex Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.